
{"id":47894,"date":"2022-07-06T18:04:36","date_gmt":"2022-07-06T17:04:36","guid":{"rendered":"https:\/\/www.btitrainingcenter.com\/potential-of-plasma-rich-in-growth-factors-prgf-endoret-to-enhance-the-efficacy-of-assisted-reproductive-techniques-in-refractory-cases\/"},"modified":"2026-04-10T13:15:26","modified_gmt":"2026-04-10T12:15:26","slug":"potential-of-plasma-rich-in-growth-factors-prgf-endoret-to-enhance-the-efficacy-of-assisted-reproductive-techniques-in-refractory-cases","status":"publish","type":"post","link":"https:\/\/www.btitrainingcenter.com\/pt-pt\/potential-of-plasma-rich-in-growth-factors-prgf-endoret-to-enhance-the-efficacy-of-assisted-reproductive-techniques-in-refractory-cases\/","title":{"rendered":"Potential of Plasma Rich in Growth Factors (PRGF-Endoret) to Enhance the Efficacy of Assisted Reproductive Techniques in Refractory Cases"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row gap=&#8221;20&#8243; content_text_aligment=&#8221;left&#8221; row_background_lines=&#8221;no&#8221;][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3 class=\"title\">Abstract<\/h3>\n<div id=\"enc-abstract\" class=\"abstract-content selected\">\n<div id=\"enc-abstract\" class=\"abstract-content selected\">\n<p><strong class=\"sub-title\">Aim:\u00a0<\/strong>Nowadays, infertility problems affect a high percentage of couples. This study aimed to evaluate the effect of plasma rich in growth factors (PRGF-Endoret, hereafter PRGF) as a promising coadjuvant therapy in assisted reproductive techniques and its possible role in implantation and pregnancy rates. This retrospective study included 36 PRGF cycles in 27 women with one of the following reproductive disorders: recurrent implantation failure (n = 16), repeated abortion (n = 8), and thin endometrium (n = 3).<\/p>\n<p><strong class=\"sub-title\">Methods:\u00a0<\/strong>PRGF was obtained from each patient and administered as three consecutive intrauterine instillations. The endometrial thickness was measured after each PRGF infusion and a good-quality embryo transfer was performed for every patient. Endometrial thickness, biochemical pregnancy, and miscarriage rate were the primary measured outcomes.<\/p>\n<p><strong class=\"sub-title\">Results:\u00a0<\/strong>PRGF increased the endometrial growth respecting the initial thickness in all cases. The biochemical pregnancy rate determined as positive beta-human chorionic gonadotropin (\u03b2-hCG) was 59%, considering the total number of patients; the ongoing pregnancy percentage was 48%. PRGF application day was relevant with a significant probability of achieving pregnancy (p &lt; 0.01) when the first PRGF infusion was carried out beyond 6.5 days after the first day of the woman&#8217;s cycle and the second one beyond 9.5 days of the menstrual cycle.<\/p>\n<p><strong class=\"sub-title\">Conclusions:\u00a0<\/strong>Intrauterine autologous PRGF infusion is a safe, easily accessible, and inexpensive therapy that could collaborate in fertility treatments by optimizing the endometrium for implantation and thus favoring the crosstalk between the embryo and the uterus improving the embryo-maternal dialogue.<\/p>\n<\/div>\n<p><strong class=\"sub-title\">Keywords:\u00a0<\/strong>assisted reproductive techniques; blastocyst; implantation; infertility; platelet-rich plasma.<\/p>\n<\/div>\n<p>[\/vc_column_text][vc_empty_space][vc_column_text]<\/p>\n<h3>Figures<\/h3>\n<p>[\/vc_column_text][vc_empty_space][\/vc_column][vc_column width=&#8221;1\/4&#8243; css=&#8221;.vc_custom_1775822114989{margin-top: 80px !important;margin-right: 5% !important;margin-left: 30px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;background-color: #F6F6F6 !important;border-radius: 25px !important;}&#8221;]<div class=\"qodef-animation-holder qodef-grow-in\" data-animation=\"qodef-grow-in\" data-animation-delay=\"\"><div class=\"qodef-animation-inner\">[vc_column_text css=&#8221;&#8221;]<em>Aceda \u00e0 brochura da BTI:<\/em>[\/vc_column_text][vc_single_image image=&#8221;45554&#8243; img_size=&#8221;medium&#8221; alignment=&#8221;center&#8221; onclick=&#8221;custom_link&#8221; img_link_target=&#8221;_blank&#8221; css=&#8221;&#8221; link=&#8221;https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/7.-USA_CASOS_REFRACTARIOS.pdf&#8221;]<a itemprop=\"url\" href=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/7.-USA_CASOS_REFRACTARIOS.pdf\" target=\"_blank\" style=\"margin: 15px 5px 3px 33px\" class=\"qodef-btn qodef-btn-medium qodef-btn-solid btnWebRosa2 text12\"  >\n    <span class=\"qodef-btn-text\">Aceda ao pdf<\/span>\n    <\/a><\/div><\/div>[\/vc_column][\/vc_row][vc_row content_placement=&#8221;middle&#8221; content_text_aligment=&#8221;center&#8221;][vc_column]<div class=\"qodef-image-gallery qodef-grid-list qodef-disable-bottom-space  qodef-ig-grid-type qodef-four-columns qodef-tiny-space  qodef-image-behavior-lightbox\">\n\t<div class=\"qodef-ig-inner qodef-outer-space\">\n\t\t\t\t\t<div class=\"qodef-ig-image qodef-item-space\">\n\t\t\t\t<div class=\"qodef-ig-image-inner\">\n\t\t\t\t\t\t\t\t\t\t\t<a itemprop=\"image\" class=\"qodef-ig-lightbox\" href=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/cureus-0014-00000026623-i01.jpg\" data-rel=\"prettyPhoto[image_gallery_pretty_photo-486]\" title=\"&lt;strong&gt; Figure 1. Endometrial thickness &lt;\/strong&gt; Endometrial thickness progression. The endometrium thickness (in mm) after each PRGF application was measured with ultrasound. The graph shows the variation in each group (RIF or recurrent implantation failure, RA or repeated abortion, and TE or thin endometrium) and in the total number of patients. PRGF: plasma rich in growth factors; RIF: recurrent implantation failure; RA: repeated abortion.\">\n\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/cureus-0014-00000026623-i01-200x200.jpg\" alt=\"\" width=\"200\" height=\"200\" \/>\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>[vc_empty_space height=&#8221;50px&#8221;][\/vc_column][\/vc_row][vc_row][vc_column]<a itemprop=\"url\" href=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/7.-cureus-0014-00000026623.pdf\" target=\"_blank\"  class=\"qodef-btn qodef-btn-medium qodef-btn-solid btnWebRosa2\"  >\n    <span class=\"qodef-btn-text\">Descarregar artigo<\/span>\n    <\/a>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p><strong>Cureus. 2022 Jul 6;14(7):e26623.<\/strong><br \/>\nNowadays, infertility problems affect a high percentage of couples. This study aimed to evaluate the effect of plasma rich in growth factors (PRGF-Endoret, hereafter PRGF) as a promising coadjuvant therapy in assisted reproductive techniques and its possible role in implantation and pregnancy rates. This retrospective study included 36 PRGF cycles in 27 women with one of the following reproductive disorders: recurrent implantation failure (n = 16), repeated abortion (n = 8), and thin endometrium (n = 3).<\/p>\n","protected":false},"author":2002,"featured_media":45554,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[158],"tags":[],"class_list":["post-47894","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicina-regenerativa-pt-pt"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/posts\/47894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/users\/2002"}],"replies":[{"embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=47894"}],"version-history":[{"count":2,"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/posts\/47894\/revisions"}],"predecessor-version":[{"id":47896,"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/posts\/47894\/revisions\/47896"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/media\/45554"}],"wp:attachment":[{"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=47894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/categories?post=47894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=47894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}